Clinical Trials Browser

INDUSTRY × Alopecia × Doxorubicin × Clear all

NCT05622058 2023-02-27

A Study of ALRN-6924 for Protection of Chemotherapy-Induced Side Effects in Patients With TP53-Mutant Breast Cancer

Phase 1 Terminated

Alopecia, Breast Neoplasms, Neutropenia